The team Partenariats gathers people with various backgrounds, multiple experiences and complementary expertises:

Corentin Chaboud

Corentin CHABOUD, European and international affairs manager/grant office

Corentin has a sound and practical knowledge of European and international funding tools; he spent 7 years in Brussels and graduated from one of the Instituts d’études politiques (Institutes of Political Studies). He can match a project idea with a suitable funding scheme (Horizon 2020, IMI, Joint Programming Initiatives, international foundations, etc.) thanks to his understanding of the relevant rules, benefits and constraints. His network in Brussels and Europe is a valuable asset.

Charles Henry

Charles Henry DION, Strategic Partnership Manager – Antimicrobial

Charles joined BIOASTER in January 2019 as a strategic partnership manager in antimicrobials. Prior to that, he spent 7 years at Business France providing business development support to French innovative companies as Head of North American healthcare department. He started his career both in academic research (CNRS, Inserm) and industrial (Sanofi Pasteur), before working in Belgium for a Life Science consulting firm (Altran) for clients like GSK. Charles received his biotech engineering degree from Polytech’Marseille and MBA from Kedge Business School, France.

Sara FRÖJDÖ, Strategic Partnership Manager – Diagnostic

After a Masters degree in Genetics from Helsinki University, Sara obtained a PhD in molecular biology from University of Lyon (INSERM/INRA). Then, she spent 10 years at Alcimed, in international innovation and new business development consulting. This has allowed her to work with multiple key decision makers from both big life science industries, SMEs and start-ups. She joined our Strategic Partnership office in Diagnostic program since November 2018.

Alexis Rideau

Alexis RIDEAU, Strategic Partnership Manager – Microbiota

Alexis has acquired a solid experience in innovation management within multidisciplinary teams, through an international scientific and business background in renowned academic institutions (PhD in molecular and cellular biology – University of Cambridge/Wellcome Trust; MBA in International Management – ESCP Europe Business School), analyst activities in the venture capital sector (Library House Ltd, Cambridge; Bionest Partners Finance, Paris) and business development positions in innovative sectors (Glaizer Group; MorphoSys AG; Bio-Rad Laboratories).